Roboz, Gail J <br/><br/>
Phase I trial of plerixafor combined with decitabine in newly diagnosed older patients with acute myeloid leukemia.  [electronic resource] 

 -  Haematologica  08 2018 
 - 1308-1316 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1592-8721 
<br/><br/><label>Standard No.: </label>10.3324/haematol.2017.183418  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Benzylamines<br/>Cell Movement<br/>Cyclams<br/>Decitabine--therapeutic use<br/>Female<br/>Heterocyclic Compounds--therapeutic use<br/>Humans<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Male<br/>Maximum Tolerated Dose<br/>Middle Aged<br/>Receptors, CXCR4--antagonists & inhibitors<br/>Treatment Outcome